Link
Vaccines and treatments for COVID-19: Safety after authorization
Organization: Public Health Agency of Canada (PHAC)Published: 2021
"This webpage provides information on safety after authorization of vaccines and treatments for COVID-19. The following topics are included: safety after authorization (pharmacovigilance), monitoring COVID-19 variants, reporting safety concerns for vaccines, treatment safety and reporting safety concerns for drugs, and videos, posters, and infographics to share." - Public Health Agency of Canada
Resource Group:
Implementation Tool
Product Type: Guide
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Vaccine Monitoring and Surveillance
Vaccine Monitoring
Product Type: Guide
Category:
Vaccine Safety and Development,Vaccine Safety,Adverse Events Following Immunization (AEFI),Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Vaccine Monitoring and Surveillance,Vaccine Monitoring Vaccine Safety and DevelopmentVaccine Safety
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Vaccine Monitoring and Surveillance
Vaccine Monitoring
Audience:
Health Care Professional
Population: Seniors
High Risk Adults
Healthcare Personnel
Indigenous Populations
Children (All)
High Risk Children
Region: National
Population: Seniors
High Risk Adults
Healthcare Personnel
Indigenous Populations
Children (All)
High Risk Children
Region: National
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.